Prof Jonathan Benger is currently deputy CEO of the health technology assessment (HTA) agency. Prof Jonathan Benger will take over from Dr Samantha Roberts as chief executive of UK reimbursement ...

Thousands of men with advanced prostate cancer will be offered a new treatment, Pfizer's Talzenna, from today after NICE made an about-turn on the drug. The reimbursement authority said last year that ...

For a definitive list of which limits are mandatory please visit the submission checklist page. We allow the use of up to 6 keywords/key phrases that can be used for indexing purposes. These should ...